Chen J - Search Results

1

Preparation and characterization of SARS in-house reference antiserum.

Zhang J, Liu Y, Hu L, Gao Q, Zhang Z, Zhang X, Chen J, Gong X, Song L, Liu Y, Li J, Li S, Huang J, Ning Y, Gao H, Qin C, Dong X, Wei J, Dong G, Yin W. Zhang J, et al. Among authors: chen j. Vaccine. 2005 Dec 1;23(48-49):5666-9. doi: 10.1016/j.vaccine.2004.12.032. Epub 2005 Mar 16. Vaccine. 2005. PMID: 16269206 Free PMC article.

2

A serological survey on neutralizing antibody titer of SARS convalescent sera.

Zhang JS, Chen JT, Liu YX, Zhang ZS, Gao H, Liu Y, Wang X, Ning Y, Liu YF, Gao Q, Xu JG, Qin C, Dong XP, Yin WD. Zhang JS, et al. J Med Virol. 2005 Oct;77(2):147-50. doi: 10.1002/jmv.20431. J Med Virol. 2005. PMID: 16121363 Free PMC article.

3

Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.

Wu J, Liu SZ, Dong SS, Dong XP, Zhang WL, Lu M, Li CG, Zhou JC, Fang HH, Liu Y, Liu LY, Qiu YZ, Gao Q, Zhang XM, Chen JT, Zhong X, Yin WD, Feng ZJ. Wu J, et al. Among authors: chen jt. Vaccine. 2010 Aug 31;28(38):6221-7. doi: 10.1016/j.vaccine.2010.07.008. Epub 2010 Jul 16. Vaccine. 2010. PMID: 20638454 Clinical Trial.

4

[Serological investigation on close contacts to patients with severe acute respiratory syndrome in an SARS outbreak].

Xie SY, Zeng G, Chen JT, Liu YX, Li SF, Yin WD. Xie SY, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Oct;25(10):867-9. Zhonghua Liu Xing Bing Xue Za Zhi. 2004. PMID: 15631743 Chinese.

5

Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine.

Lin JT, Zhang JS, Su N, Xu JG, Wang N, Chen JT, Chen X, Liu YX, Gao H, Jia YP, Liu Y, Sun RH, Wang X, Yu DZ, Hai R, Gao Q, Ning Y, Wang HX, Li MC, Kan B, Dong GM, An Q, Wang YQ, Han J, Qin C, Yin WD, Dongs XP. Lin JT, et al. Among authors: chen jt, chen x. Antivir Ther. 2007;12(7):1107-13. Antivir Ther. 2007. PMID: 18018769 Clinical Trial.

6

Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.

Wu J, Zhong X, Li CK, Zhou JF, Lu M, Huang KY, Dong M, Liu Y, Luo FJ, Du N, Chui C, Liu LQ, Smith NM, Li B, Shi NM, Song LF, Gao Y, Wang DY, Wang X, Zhu WF, Yan Y, Li Z, Chen JT, McMichael AJ, Yin WD, Xu XN, Shu Y. Wu J, et al. Among authors: chen jt. Vaccine. 2011 Jan 29;29(5):1009-16. doi: 10.1016/j.vaccine.2010.11.058. Epub 2010 Dec 2. Vaccine. 2011. PMID: 21130194 Clinical Trial.

7

[Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus].

Guo W, Xu J, Wu J, Zhao S, He H, Shi W, Yu D, Li J, Gao H, Chen J. Guo W, et al. Among authors: chen j. Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Aug;35(8):949-52. Zhonghua Liu Xing Bing Xue Za Zhi. 2014. PMID: 25376689 Clinical Trial. Chinese.

8

Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.

Wu J, Fang HH, Chen JT, Zhou JC, Feng ZJ, Li CG, Qiu YZ, Liu Y, Lu M, Liu LY, Dong SS, Gao Q, Zhang XM, Wang N, Yin WD, Dong XP. Wu J, et al. Among authors: chen jt. Clin Infect Dis. 2009 Apr 15;48(8):1087-95. doi: 10.1086/597401. Clin Infect Dis. 2009. PMID: 19281330 Clinical Trial.

9

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

Lin J, Zhang J, Dong X, Fang H, Chen J, Su N, Gao Q, Zhang Z, Liu Y, Wang Z, Yang M, Sun R, Li C, Lin S, Ji M, Liu Y, Wang X, Wood J, Feng Z, Wang Y, Yin W. Lin J, et al. Among authors: chen j. Lancet. 2006 Sep 16;368(9540):991-7. doi: 10.1016/S0140-6736(06)69294-5. Lancet. 2006. PMID: 16980114 Clinical Trial.

10

Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine.

Lin JT, Li CG, Wang X, Su N, Liu Y, Qiu YZ, Yang M, Chen JT, Fang HH, Dong XP, Yin WD, Feng ZJ. Lin JT, et al. J Infect Dis. 2009 Jan 15;199(2):184-7. doi: 10.1086/595832. J Infect Dis. 2009. PMID: 19067606 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128,373 results

Search Page